Stockreport

MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent

MAIA Biotechnology, Inc.  (MAIA) 
PDF New science for cancer therapy drives powerful value propositionExceptional measures of efficacy by lead drug THIO in Phase 2 clinical trialFunding of more than $12M yea [Read more]